Caroline Nebhan is a medical oncologist at Intermountain Health in Murray, Utah. She completed her medical and graduate training at Vanderbilt University in Nashville, Tennessee. Under the direction of William Pao, MD, PhD, her graduate work focused on the development of acquired resistance to targeted therapies in EGFR-mutant lung cancer. As a fellow, she worked with Ann Richmond, PhD and Doug Johnson, MD, MSCI to study novel combinations of targeted therapy and immune therapy in the treatment of melanoma using preclinical models and patient specimens.  At Intermountain, she specializes in the treatment of cutaneous malignancy and serves at the director of the melanoma program, where she serves as the PI of clinical trials to advance the treatment of melanoma.